GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » SynBiotic SE (XTER:SBX) » Definitions » Total Stockholders Equity

SynBiotic SE (XTER:SBX) Total Stockholders Equity : €15.79 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is SynBiotic SE Total Stockholders Equity?

SynBiotic SE's Total Stockholders Equity for the quarter that ended in Dec. 2023 was €15.79 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. SynBiotic SE's Book Value per Share for the quarter that ended in Dec. 2023 was €3.15. The ratio of a company's debt over equity can be used to measure how leveraged this company is. SynBiotic SE's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.23.

SynBiotic SE Total Stockholders Equity Historical Data

The historical data trend for SynBiotic SE's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SynBiotic SE Total Stockholders Equity Chart

SynBiotic SE Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Stockholders Equity
Get a 7-Day Free Trial 0.24 25.49 35.00 22.59 15.79

SynBiotic SE Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Dec23
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only 43.17 35.00 52.42 22.59 15.79

SynBiotic SE  (XTER:SBX) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

SynBiotic SE's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(15.79-0)/5.00488
=3.15

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

SynBiotic SE's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0.787 + 2.893) / 15.79
=0.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SynBiotic SE Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of SynBiotic SE's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

SynBiotic SE Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » SynBiotic SE (XTER:SBX) » Definitions » Total Stockholders Equity
Comparable Companies
XTER:PA8 XTER:B8F ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692 NSE:DIVISLAB BOM:500124 VTRS NBIX SZSE:000963 SHSE:600085 XPAR:IPN SHSE:600196
Traded in Other Exchanges
SBX:Germany
Address
Barer Strasse 7, Munich, BY, DEU, 80333
Website
https://www.synbiotic.com
SynBiotic SE is engaged in the development of Phyto-cannabinoids and other herbal compounds concentrated molecules as well as the development of wellness products. The company engages in synthetic production, drug development, cannabinoids, dietary supplements and cosmetic products. Geographical presence in Germany, Austria, UK, Switzerland and Other countries. Majority of its revenue comes from domestic market.
Executives
Daniel Kruse Geschäftsführender Direktor

SynBiotic SE Headlines

No Headlines